Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Number and proportion of women responding to annual questionnaires by trial arm in the EPHT Trial, 1999–2004

From: Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial

Trial arm Recruitment N (%) 1st year N (%) 2nd year N (%) Final N (%)
Blind HT 415 (100) 315 (75.9) 295 (71.1) 329 (79.3)
Blind placebo 381 (100) 278 (73.0) 254 (66.7) 308 (80.8)
Non-blind HT 503 (100) 371 (73.8) 340 (67.6) 405 (80.5)
Non-treatment 524 (100) 395 (75.4) 374 (71.4) 445 (84.9)
Total 1823 (100) 1359 (74.6) 1263 (69.3) 1487 (81.4)